Article Versions Notes

Shabaneh S, Berry EM, Imam A, Suki M, Salhab A, Khalaileh A, Safadi R. Hepatic Copper Accumulation Predicts Fibrosis Progression and Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Nutrients. 2025; 17(18):2923. https://doi.org/10.3390/nu17182923

Shabaneh, Suha, Elliot M. Berry, Ashraf Imam, Mohamad Suki, Ahmad Salhab, Abed Khalaileh, and Rifaat Safadi. 2025. "Hepatic Copper Accumulation Predicts Fibrosis Progression and Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)" Nutrients 17, no. 18: 2923. https://doi.org/10.3390/nu17182923

Shabaneh, S., Berry, E. M., Imam, A., Suki, M., Salhab, A., Khalaileh, A., & Safadi, R. (2025). Hepatic Copper Accumulation Predicts Fibrosis Progression and Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Nutrients, 17(18), 2923. https://doi.org/10.3390/nu17182923